Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers
Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit from adding immunotherapy to current standard treatments, while a…